March 22, 2021
Decibel Therapeutics
Decibel Therapeutics Added to Russell 2000 Index
March 22, 2021
Sesen Bio and Qilu Pharmaceutical Announce Approval of IND Application in China for Vicineum™
March 18, 2021
Fulcrum Therapeutics
Fulcrum Therapeutics Presents Data for Potential FSHD Biomarker and Clinical Outcome Assessments at 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference
March 16, 2021
Pliant Therapeutics
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
March 16, 2021
Pliant Therapeutics
Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner